Fulgent Genetics, Inc.
—- Market cap
- —
- Debt
- +$476.00K
- Cash
- −$70.19M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: FLGT stock price vs ABT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ABT's multiple
Needs ABT P/S.
Implied fair value · at FLGT's multiple
Needs FLGT P/S.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FLGT FY 2025 (ended Dec 31, 2025) · ABT FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
FULGENT GENETICS, INC. · implied price per share
Bear
-$15.71
Base
-$18.48
Bull
-$21.26
ABBOTT LABORATORIES · implied price per share
Bear
$46.69
Base
$54.92
Bull
$63.16
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.00x
0.31x
Net debt / EBITDA
Leverage against operating earnings
1.62x
0.55x
Cash and equivalents
Liquid reserves on the balance sheet
$70.19M
$8.94B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
FLGT vs NEO
Natera, Inc.
FLGT vs NTRA
Guardant Health, Inc.
FLGT vs GH
EXACT SCIENCES CORP
FLGT vs EXAS
OPKO HEALTH, INC.
FLGT vs OPK
Johnson & Johnson
FLGT vs JNJ
Medtronic plc
FLGT vs MDT
BECTON DICKINSON & CO
FLGT vs BDX
Thermo Fisher Scientific Inc.
FLGT vs TMO
DANAHER CORP /DE/
FLGT vs DHR
BOSTON SCIENTIFIC CORP
FLGT vs BSX
$476.00K
$15.96B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote